Liu Y, Zhou HL, Hou YF, Zhang J. miR-214 down-regulates Sema4D expression in colon cancer LoVo cells.
Shijie Huaren Xiaohua Zazhi 2015;
23:1115-1120. [DOI:
10.11569/wcjd.v23.i7.1115]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To observe the effect of miR-214 on Sema4D expression in human colon cancer cell line LoVo.
METHODS: miR-214 mimic, miR-214 inhibitor, and two control sequences (mi-control, in-control) were designed, synthesized and transfected into LoVo cells, respectively. RT-PCR was used to detect the expression changes of miR-214 and Sema4D mRNA in transfected cells, and the expression change of Sema4D protein was detected by Western blot.
RESULTS: The relative expression levels of miR-214 in LoVo cells transfected with miR-214 mimic, mi-control, miR-214 inhibitor, and in-control were 8.003 ± 0.651, 3.464 ± 0.332, 0.740 ± 0.088, and 2.620 ± 0.166, respectively. The expression of miR-214 increased significantly in the mimic group compared with the control group, but was significantly lower in the inhibitor group than in the control group (P < 0.05). The relative expression levels of Sema4D mRNA in LoVo cells transfected with miR-214 mimic, mi-control, miR-214 inhibitor, and in-control were 0.420 ± 0.027, 0.851 ± 0.062, 1.243 ± 0.087, and 0.660 ± 0.042, respectively, and the relative expression levels of Sema4D protein were 0.163 ± 0.037, 0.550 ± 0.038, 1.137 ± 0.112, and 0.457 ± 0.046, respectively. Sema4D mRNA and protein expression in the mimic group was decreased significantly compared with the control group, but was significantly increased in the inhibitor group compared with the control group (P < 0.05).
CONCLUSION: Sema4D expression is regulated by miR-214 in human colon cancer cell line LoVo, and miR-214 can down-regulate the expression of Sema4D mRNA and thereby influence the protein expression. miR-214 could be used as a new target for treatment of colon carcinoma.
Collapse